Cargando…

Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective()

OBJECTIVE: Persons with schizophrenia exhibit greater neurocognitive test score dispersion. Here, we seek to characterize dispersion on the Neurocognitive Composite subtests of the Measurement of Treatment Research to Improve Cognition in Schizophrena Consensus Cognitive Battery (MCCB) and determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williamson, David J., Nuechterlein, Keith H., Tishler, Todd, Ventura, Joseph, Ellingson, Benjamin M., Turkoz, Ibrahim, Keefe, Richard S.E., Alphs, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468588/ https://www.ncbi.nlm.nih.gov/pubmed/36111288 http://dx.doi.org/10.1016/j.scog.2022.100270

Ejemplares similares

The relationship between IQ and performance on the MATRICS consensus cognitive battery
por: Mohn, Christine, et al.
Publicado: (2014)

Healthy Adolescent Performance With Standardized Scoring Tables for the MATRICS Consensus Cognitive Battery: A Multisite Study
por: Smelror, Runar Elle, et al.
Publicado: (2019)

Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients
por: Zhang, Baohua, et al.
Publicado: (2017)

The Polish Academic Version of the MATRICS Consensus Cognitive Battery (MCCB): Evaluation of Psychometric Properties
por: Jędrasik-Styła, Małgorzata, et al.
Publicado: (2015)

Validity of remote administration of the MATRICS Consensus Cognitive Battery for individuals with severe mental illness
por: Russell, Madisen T., et al.
Publicado: (2021)

Meta-analysis of cognitive function in Chinese first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) profile of impairment
por: Zhang, Huijuan, et al.
Publicado: (2019)

Dysfunction of Cognition Patterns Measured by MATRICS Consensus Cognitive Battery (MCCB) among First Episode Schizophrenia Patients and Their Biological Parents
por: CAO, Aiai, et al.
Publicado: (2017)

Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis
por: Bo, Qijing, et al.
Publicado: (2017)

The MATRICS Consensus Cognitive Battery: Psychometric Properties of the Chinese Version in Young Patients With Major Depression Disorder
por: Liang, Sixiang, et al.
Publicado: (2021)

T72. COGNITIVE CLUSTERS IN FIRST-EPISODE PSYCHOSIS AND THEIR RELATIONSHIP TO SYMPTOMATOLOGY AND DEVELOPMENTAL SCHOLASTIC PERFORMANCE
por: Tan, Eric, et al.
Publicado: (2020)

Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder
por: Bossie, Cynthia A., et al.
Publicado: (2017)

11. AEROBIC EXERCISE TRAINING FOR INDIVIDUALS WITH SCHIZOPHRENIA: THE BROAD BENEFITS ACROSS PHYSICAL HEALTH, COGNITION, AND EVERYDAY FUNCTIONING AND PROMISING MECHANISMS OF ACTION
por: Nuechterlein, Keith
Publicado: (2018)

11.4 AEROBIC EXERCISE ENHANCES COGNITIVE TRAINING EFFECTS IN FIRST EPISODE SCHIZOPHRENIA: COGNITIVE AND FUNCTIONAL GAINS AND PROMISING BIOLOGICAL MECHANISMS OF ACTION
por: Nuechterlein, Keith, et al.
Publicado: (2018)

Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms
por: Macfadden, Wayne, et al.
Publicado: (2011)

Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia
por: Sliwa, Jennifer Kern, et al.
Publicado: (2012)

Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate
por: Sliwa, Jennifer Kern, et al.
Publicado: (2014)

Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies
por: Markowitz, Michael, et al.
Publicado: (2013)

Benefit–risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia
por: Levitan, Bennett, et al.
Publicado: (2016)

Cognitive impairment in psychotic illness: prevalence, profile of impairment, developmental course, and treatment considerations 
por: McCleery, Amanda, et al.
Publicado: (2019)

Aerobic exercise enhances cognitive training effects in first-episode schizophrenia: randomized clinical trial demonstrates cognitive and functional gains
por: Nuechterlein, Keith H., et al.
Publicado: (2023)

Consensus Paper: Cerebellum and Social Cognition
por: Van Overwalle, Frank, et al.
Publicado: (2020)

Early Visual Processing Is Associated With Social Cognitive Performance in Recent-Onset Schizophrenia
por: McCleery, Amanda, et al.
Publicado: (2020)

Validity of the Montreal Cognitive Assessment (MoCA) Index Scores: a Comparison with the Cognitive Domain Scores of the Seoul Neuropsychological Screening Battery (SNSB)
por: Kim, Haeyoon, et al.
Publicado: (2021)

O4.1. AEROBIC EXERCISE DOSE DETERMINES THE COGNITIVE GAIN IN FIRST-EPISODE SCHIZOPHRENIA, SO HOW DO WE ENCOURAGE SUFFICIENT EXERCISE?
por: Nuechterlein, Keith, et al.
Publicado: (2020)

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder
por: Fu, Dong-Jing, et al.
Publicado: (2016)

On the psychometric evaluation of cognitive control tasks: An Investigation with the Dual Mechanisms of Cognitive Control (DMCC) battery
por: Snijder, Jean-Paul, et al.
Publicado: (2023)

The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia
por: Marder, Stephen R.
Publicado: (2006)

Pharmacological Interventions for the MATRICS Cognitive Domains in Schizophrenia: What’s the Evidence?
por: Vingerhoets, Wilhelmina A. M., et al.
Publicado: (2013)

Consensus clustering approach to group brain connectivity matrices
por: Rasero, Javier, et al.
Publicado: (2017)

Validation of the NIH Toolbox Cognitive Battery in intellectual disability
por: Shields, Rebecca H., et al.
Publicado: (2020)

Clinically meaningful changes on depressive symptom measures and patient‐reported outcomes in patients with treatment‐resistant depression
por: Turkoz, Ibrahim, et al.
Publicado: (2021)

Mild Cognitive Impairment: the Manchester consensus
por: Dunne, Ross A, et al.
Publicado: (2020)

Normative Scores for Malayalam Cognitive Screening Test Battery among Older Adults in Kerala, India
por: Radhakrishnan, Priya Jyothishmathy, et al.
Publicado: (2023)

Validity of a novel computerized cognitive battery for mild cognitive impairment
por: Dwolatzky, Tzvi, et al.
Publicado: (2003)

Should dispersers be fast learners? Modeling the role of cognition in dispersal syndromes
por: Liedtke, Jannis, et al.
Publicado: (2021)

T59. VIRTUAL REALTY ASSESSMENT OF FUNCTIONAL CAPACITY IN EARLY SCHIZOPHRENIA: ASSOCIATIONS WITH NEUROCOGNITION, FUNCTIONAL CAPACITY PERFORMANCE, AND DAILY FUNCTIONING
por: Ventura, Joseph, et al.
Publicado: (2018)

Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery
por: De Meijer, L, et al.
Publicado: (2018)

Asynchronous Remote Assessment for Cognitive Impairment: Reliability Verification of the Neurotrack Cognitive Battery
por: Myers, Jennifer Rae, et al.
Publicado: (2022)

Home Improvement: Evaluating Secular Changes in NLSY HOME-Cognitive Stimulation and Emotional Support Scores
por: O’Keefe, Patrick, et al.
Publicado: (2021)

Feasibility study to evaluate capabilities for conducting psychiatric clinical research within the Rwandan mental healthcare system
por: Alphs, Larry, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1tebb0npsp02ff578hoov9ud2q